Bronchiectasis: Comparing Antibiotic Treatments for PA Infection

We are studying two antibiotic regimens to see which is more effective for adults with bronchiectasis and early Pseudomonas aeruginosa infections. This research may help improve treatment options for these patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Ceftazidime Pentahydrate
Ceftazidime pentahydrate is an antibiotic substance used to treat serious bacterial infections, especially those caused by Gram-negative bacteria like Pseudomonas.
Ciprofloxacin
Ciprofloxacin is an antibiotic used to treat various bacterial infections, such as urinary, respiratory, and skin infections.
Colistimethate Sodium
Colistimethate sodium is an antibiotic substance used to treat severe infections caused by certain antibiotic-resistant bacteria.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire Amiens Picardie
pneumology
Amiens, France
Hopital Tenon
pneumology
Bagnolet, France
Centre Hospitalier Regional Et Universitaire De Brest
pneumology
Brest, France

Sponsor: Centre Hospitalier Intercommunal Creteil
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.